February 19, 2026
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.
February 17, 2026
Published in Cell Reports Medicine, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy response.
February 16, 2026
The tool is a one-stop resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.
February 4, 2026
CHAPEL HILL, N.C. – Feb. 4, 2026 – A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine how powerful immune cells—known as CD8 killer T cells—choose between becoming long-lasting, protective defenders or slipping into exhausted, …
January 2, 2026
The research, led by Nobel laureate and biochemist Aziz Sancar, MD, PhD, could revolutionize treatments for glioblastoma, an aggressive and deadly form of brain cancer.
October 28, 2025
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR T-cell therapy to better fight off melanoma.
October 20, 2025
A new multi-site study, co-led by researchers at the UNC Lineberger Comprehensive Cancer Center and Wake Forest University School of Medicine, has demonstrated that a direct-to-patient digital health program can significantly increase recommended lung cancer screening for high-risk individuals.
October 8, 2025
A decade after winning the Nobel Prize, the UNC professor continues to push the boundaries of discovery while inspiring the next generation and building cultural bridges between the United States and Türkiye.
September 24, 2025
Chemtai Mungo, MD, MPH, FACOG, has been awarded $2.5M over five years by the National Institutes of Health for her research focused on improving human papillomavirus treatment outcomes in women living with HIV in Africa.
September 23, 2025
Experts at the UNC School of Medicine played a pivotal role in the approval of a new medication for pediatric patients that could also be used to treat other types of cancer.
September 19, 2025
Each year, the Postdoctoral Awards for Research Excellence (PARE) are given in recognition of the research promise demonstrated by individual postdoctoral scholars.
August 11, 2025
In a surprising twist, UNC scientists discovered that SETD2, a tumor suppressor, also preserves nuclear structure during cell division—a hidden role that may explain its tumor-suppressive effects in cancer.